We present case histories of four patients treated with artemether-lumefantrine for falciparum malaria in UK hospitals in 2015 to 2016. Each subsequently presented with recurrent symptoms and Plasmodium falciparum parasitemia within 6 weeks of treatment with no intervening travel to countries where malaria is endemic. Parasite isolates, all of African origin, harbored variants at some candidate resistance loci. No evidence of pfk13-mediated artemisinin resistance was found. Vigilance for signs of unsatisfactory antimalarial efficacy among imported cases of malaria is recommended
BACKGROUND: Imported cases of multidrug resistant Plasmodium falciparum and treatment failure with ...
BACKGROUND: Studies in Southeast Asia reported a strong relationship between polymorphisms at the pr...
Background: The spread of drug resistance has seriously impacted the effective treatment of infectio...
ABSTRACT: The failure of artemisinin combination therapy (ACT) in malaria patients returning from en...
BACKGROUND: The screening of lead compounds against in vitro parasite cultures is an essential step ...
OBJECTIVES: We sought to identify chloroquine-resistant Plasmodium falciparum parasites among 66 tra...
Antimalarial interventions have yielded a significant decline in malaria prevalence in The Gambia, w...
Antimalarial interventions have yielded a significant decline in malaria prevalence in The Gambia, w...
Artemisinin resistance (delayed P. falciparum clearance following artemisinin-based combination ther...
Background. Artemether-lumefantrine (AL) is a major and highly effective artemisinin-based combinati...
Background: Imported cases of multidrug resistant Plasmodium falciparum and treatment failure with a...
BACKGROUND: Malaria (Plasmodium spp) remains a top cause of travel-associated morbidity among Europe...
The artemisinin-based combination therapies artemether-lumefantrine (AL) and amodiaquine (AQ) plus a...
Background: Imported cases of multidrug resistant Plasmodium falciparum and treatment failure with a...
BACKGROUND: The Plasmodium falciparum multidrug resistance 1 (PfMDR1), P. falciparum Ca(2+)-ATPase (...
BACKGROUND: Imported cases of multidrug resistant Plasmodium falciparum and treatment failure with ...
BACKGROUND: Studies in Southeast Asia reported a strong relationship between polymorphisms at the pr...
Background: The spread of drug resistance has seriously impacted the effective treatment of infectio...
ABSTRACT: The failure of artemisinin combination therapy (ACT) in malaria patients returning from en...
BACKGROUND: The screening of lead compounds against in vitro parasite cultures is an essential step ...
OBJECTIVES: We sought to identify chloroquine-resistant Plasmodium falciparum parasites among 66 tra...
Antimalarial interventions have yielded a significant decline in malaria prevalence in The Gambia, w...
Antimalarial interventions have yielded a significant decline in malaria prevalence in The Gambia, w...
Artemisinin resistance (delayed P. falciparum clearance following artemisinin-based combination ther...
Background. Artemether-lumefantrine (AL) is a major and highly effective artemisinin-based combinati...
Background: Imported cases of multidrug resistant Plasmodium falciparum and treatment failure with a...
BACKGROUND: Malaria (Plasmodium spp) remains a top cause of travel-associated morbidity among Europe...
The artemisinin-based combination therapies artemether-lumefantrine (AL) and amodiaquine (AQ) plus a...
Background: Imported cases of multidrug resistant Plasmodium falciparum and treatment failure with a...
BACKGROUND: The Plasmodium falciparum multidrug resistance 1 (PfMDR1), P. falciparum Ca(2+)-ATPase (...
BACKGROUND: Imported cases of multidrug resistant Plasmodium falciparum and treatment failure with ...
BACKGROUND: Studies in Southeast Asia reported a strong relationship between polymorphisms at the pr...
Background: The spread of drug resistance has seriously impacted the effective treatment of infectio...